Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

December 04, 2007 09:01 ET

Meridian's CSA Mark Leads to Distribution Agreement With Henry Schein Ash Arcona

A subsidiary of Henry Schein, Inc., the Largest Distributor of Healthcare Products in North America

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 4, 2007) - Meridian Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that it has been granted CSA's Certificate of Compliance for its Digital Pulse Analyzer (DPA). This certification is required by leading medical companies for distribution, and for hospitals and fitness centers to carry medical devices across North America.

Meridian and Henry Schein Ash Arcona ("HSAA"), the Canadian counterpart to Henry Schein, Inc., have been in negotiations for the distribution of the DPA and the CSA mark has led both companies to reach an agreement for HSAA to market, promote and distribute the Digital Pulse Analyzer throughout Canada.

About Henry Schein Ash Arcona Inc.

Henry Schein Ash Arcona is Canada's fastest growing Healthcare distributor with equipment showrooms from coast to coast, providing quality medical supplies and equipment to healthcare offices right across the country. For more information, visit the Henry Schein Ash Arcona website at

More About: Digital Pulse Analyzer ("DPA")

The DPA accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA-cleared and Health Canada approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received approvals from FDA and other international regulatory agencies for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan, Mexico and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors, Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information